Whitney S. Henry

1.3k total citations
8 papers, 233 citations indexed

About

Whitney S. Henry is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Whitney S. Henry has authored 8 papers receiving a total of 233 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Cancer Research and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Whitney S. Henry's work include RNA modifications and cancer (3 papers), Ferroptosis and cancer prognosis (3 papers) and MicroRNA in disease regulation (2 papers). Whitney S. Henry is often cited by papers focused on RNA modifications and cancer (3 papers), Ferroptosis and cancer prognosis (3 papers) and MicroRNA in disease regulation (2 papers). Whitney S. Henry collaborates with scholars based in United States, Germany and France. Whitney S. Henry's co-authors include Alex Toker, Francisco Beça, Sandra S. McAllister, Tiffany Tsang, Andrew H. Beck, Tyler Laszewski, Andrew H. Beck, John L. Rinn, Aura Kaunisto and Lizhi He and has published in prestigious journals such as Cell, Nature Cell Biology and Cancer Research.

In The Last Decade

Whitney S. Henry

8 papers receiving 232 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Whitney S. Henry United States	6	143	90	45	40	35	8	233
Tae Hyun Kim South Korea	10	156 1.1×	92 1.0×	23 0.5×	90 2.3×	27 0.8×	14	294
Guifang Gan China	6	105 0.7×	74 0.8×	37 0.8×	100 2.5×	22 0.6×	9	226
Katrin P. Guillen United States	9	107 0.7×	54 0.6×	33 0.7×	59 1.5×	17 0.5×	14	221
Mahdi Rivandi Iran	8	134 0.9×	98 1.1×	18 0.4×	51 1.3×	25 0.7×	23	232
Shruthi Sriramkumar United States	8	191 1.3×	103 1.1×	70 1.6×	103 2.6×	23 0.7×	10	352
Kelly Graham United States	3	143 1.0×	80 0.9×	85 1.9×	41 1.0×	31 0.9×	6	276
Zhibin Lin China	9	125 0.9×	59 0.7×	31 0.7×	23 0.6×	27 0.8×	16	237
Qibing Wu China	7	85 0.6×	88 1.0×	13 0.3×	48 1.2×	25 0.7×	17	198
Junyu Wu Hong Kong	8	91 0.6×	62 0.7×	44 1.0×	49 1.2×	30 0.9×	10	226

Countries citing papers authored by Whitney S. Henry

Since Specialization

Citations

This map shows the geographic impact of Whitney S. Henry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Whitney S. Henry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Whitney S. Henry more than expected).

Fields of papers citing papers by Whitney S. Henry

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Whitney S. Henry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Whitney S. Henry. The network helps show where Whitney S. Henry may publish in the future.

Co-authorship network of co-authors of Whitney S. Henry

This figure shows the co-authorship network connecting the top 25 collaborators of Whitney S. Henry. A scholar is included among the top collaborators of Whitney S. Henry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Whitney S. Henry. Whitney S. Henry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Hwang, Daehee & Whitney S. Henry. (2025). Targeting GPX4 palmitoylation to boost antitumor immunity. Trends in cancer. 11(6). 491–492. 2 indexed citations

2.

Yang, Jia‐Shu, Andrew Morris, Koki Kamizaki, et al.. (2025). ALDH7A1 protects against ferroptosis by generating membrane NADH and regulating FSP1. Cell. 188(10). 2569–2585.e20. 8 indexed citations

3.

Böpple, Kathrin, Yaara Oren, Whitney S. Henry, et al.. (2024). ATF3 characterizes aggressive drug-tolerant persister cells in HGSOC. Cell Death and Disease. 15(4). 290–290. 7 indexed citations

4.

Levental, Kandice R. & Whitney S. Henry. (2024). Lipidomes define immune cell identity. Nature Cell Biology. 26(4). 516–518. 2 indexed citations

5.

Thomas, Clémence, Whitney S. Henry, Benjamin Cuiffo, et al.. (2017). Pentraxin-3 is a PI3K signaling target that promotes stem cell–like traits in basal-like breast cancers. Science Signaling. 10(467). 36 indexed citations

6.

Henry, Whitney S., Tyler Laszewski, Tiffany Tsang, et al.. (2016). Aspirin Suppresses Growth in PI3K-Mutant Breast Cancer by Activating AMPK and Inhibiting mTORC1 Signaling. Cancer Research. 77(3). 790–801. 103 indexed citations

7.

Henry, Whitney S., David G. Hendrickson, Francisco Beça, et al.. (2016). LINC00520 is induced by Src, STAT3, and PI3K and plays a functional role in breast cancer. Oncotarget. 7(50). 81981–81994. 40 indexed citations

8.

Kaunisto, Aura, Whitney S. Henry, Laleh Montaser‐Kouhsari, et al.. (2015). NFAT1 promotes intratumoral neutrophil infiltration by regulating IL8 expression in breast cancer. Molecular Oncology. 9(6). 1140–1154. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact